e-learning
resources
Barcelona 2013
Wednesday, 11.09.2013
Exercise, physiotherapy techniques and assessment in different chronic conditions
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: Comparison with COPD
S. Arizono, H. Taniguchi, Y. Kondoh, T. Kimura, K. Kataoka, T. Ogawa, F. Watanabe, J. Hirasawa, K. Tabira (Seto, Kita-katsurahi-gun, Hamamatsu, Japan)
Source:
Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Session:
Exercise, physiotherapy techniques and assessment in different chronic conditions
Session type:
Poster Discussion
Number:
5060
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Arizono, H. Taniguchi, Y. Kondoh, T. Kimura, K. Kataoka, T. Ogawa, F. Watanabe, J. Hirasawa, K. Tabira (Seto, Kita-katsurahi-gun, Hamamatsu, Japan). Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: Comparison with COPD. Eur Respir J 2013; 42: Suppl. 57, 5060
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Pulmonary rehabilitation in idiopathic pulmonary fibrosis: Predictors of adherence and exercise improvement
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013
Benefits of pulmonary rehabilitation and predictor of changes in exercise capacity for idiopathic pulmonary fibrosis
Source: International Congress 2014 – Latest insights in pulmonary rehabilitation
Year: 2014
The effect of pulmonary rehabilitation on exercise tolerance pulmonary function dyspnea and quality of life in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013
The six minute walking test: Clinical predictors of survival in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity
Year: 2013
Pulmonary hypertension in idiopathic pulmonary fibrosis: Utility of HRCT
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014
Contribution of home pulmonary rehabilitation in idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Integrated care and long-term strategies
Year: 2008
The effect of pulmonary rehabilitation on non COPD patients
Source: International Congress 2014 – Latest insights in pulmonary rehabilitation
Year: 2014
Assessment of nutritional status in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016
Exercise capacity in idiopathic pulmonary fibrosis and COPD
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010
The contributing factors to mean pulmonary artery pressure in idiopathic pulmonary fibrosis
Source: International Congress 2016 – Latest insights into chronic care
Year: 2016
Efficacy of pirfenidone in idiopathic pulmonary fibrosis: A single center experience
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Exercise training for idiopathic pulmonary fibrosis
Source: ERS Course 2017
Year: 2017
Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018
Pulmonary hypertension in patients with idiopathic pulmonary fibrosis
Source: Eur Respir Mon 2012; 57: 148-160
Year: 2012
Pirfenidone treatment in idiopathic pulmonary fibrosis: An Italian case series
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Pulmonary hypertension in idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010
Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – ILDs 3
Year: 2014
Validation of GAP score in Danish patients diagnosed with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Tuberculosis in patients with idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Effects of short-term pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 628s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept